Regulation of human polymorphonuclear leukocytes functions by the neuropeptide pituitary adenylate cyclase-activating polypeptide after activation of MAPKs

Journal of Immunology

Volumn 173, Issue 6, 2004, Pages 4154-4163

  Harfi, Issam ^a   D'Hondt, Stéphanie ^a   Corazza, Francis ^b   Sariban, Eric ^a,c  

^a HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

^b BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

^c Hôpital des Enfants   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CALCIUM; CD11B ANTIGEN; CYCLIC AMP; ELASTASE; G PROTEIN COUPLED RECEPTOR; GELATINASE B; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; INOSITOL TRISPHOSPHATE; LACTOFERRIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOLIPASE C; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 1; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 2;

ARTICLE; CALCIUM TRANSPORT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME RELEASE; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY BURST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 4644299546     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.6.4154     Document Type: Article

References (60)

1. Vaudry, D., B. J. Gonzalez, M. Basille, L. Yon, A. Fournier, and H. Vaudry. 2000. Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol. Rev. 52:269.
2. 2+ concentration in porcine somatotropes through common and distinct mechanisms. Cell Calcium 23:369.
3. 2+ release from ryanodine/caffeine stores through a novel pathway independent of both inositol trisphosphates and cyclic AMP in bovine adrenal medullary cells. J. Neurochem. 70:1652.
4. Langer, I., P. Vertongen, J. Perret, M. Waelbroeck, and P. Robberecht. 2002. A small sequence in the third intracellular loop of the VPAC(1) receptor is responsible for its efficient coupling to the calcium effector. Biochem. Soc. Trans. 30:447.
5. Hayez, N., I. Harfi, R. Lema-Kisoka, M. Svoboda, F. Corazza, and E. Sariban. 2004. The neuropeptides vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) modulate several biochemical pathways in human leukemic myeloid cells. J. Neuroimmunol. 149:167.
6. McRory, J., and N. M. Sherwood. 1997. Two protochordate genes encode pituitary adenylate cyclase-activating polypeptide and related family members. Endocrinology 138:2380.
7. Holmgren, S., and J. Jensen. 2001. Evolution of vertebrate neuropeptides. Brain Res. Bull. 55:723.
8. Delgado, M., and D. Ganea. 2001. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit nuclear factor-κB-dependent gene activation at multiple levels in the human monocytic cell line THP-1. J. Biol. Chem. 276:369.
9. Pozo, D. 2003. VIP- and PACAP-mediated immunomodulation as prospective therapeutic tools. Trends Mol. Med. 9:211.
10. Abad, C., C. Martinez, J. Leceta, M. G. Juarranz, M. Delgado, and R. P. Gomariz. 2002/2003. Pituitary adenylate-cyclase-activating polypeptide expression in the immune system. Neuroimmunomodulation 10:177.
11. Delgado, M., C. Abad, C. Martinez, M. G. Juarranz, A. Arranz, R. P. Gomariz, and J. Leceta. 2002. Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases. J. Mol. Med. 80:16.
12. Delgado, M., E. Garrido, M. de la Fuente, and R. P. Gomariz. 1996. Pituitary adenylate cyclase-activating polypeptide (PACAP-38) stimulates rat peritoneal macrophage functions. Peptides 17:1097.
13. Garrido, E., M. Delgado, C. Martinez, R. P. Gomariz, and M. de la Fuente. 1996. Pituitary adenylate cyclase-activating polypeptide (PACAP38) modulates lymphocyte and macrophage functions: stimulation of adherence and opposite effect on mobility. Neuropeptides 30:583.
14. Martinez, C., M. Delgado, D. Pozo, J. Leceta, J. R. Calvo, D. Ganea, and R. P. Gomariz. 1998. VIP and PACAP enhance IL-6 release and mRNA levels in resting peritoneal macrophages: in vitro and in vivo studies. J. Neuroimmunol. 85:155.
15. Kinhult, J., A. Egesten, R. Uddman, and L. O. Cardell. 2002. PACAP enhances the expression of CD11b, CD66b and CD63 in human neutrophils. Peptides 23:1735.
16. Lema-Kisoka, R., N. Hayez, I. Langer, P. Robberecht, E. Sariban, and C. Delporte. 2001. Characterization of functional VIP/PACAP receptors in the human erythroleukemic HEL cell line. Peptides 22:2155.
17. Freson, K., H. Hashimoto, C. Thys, C. Wittevrongel, S. Danloy, Y. Morita, N. Shintani, Y. Tomiyama, J. Vermylen, M. F. Hoylaerts, A. Baba, and C. Van Geet. 2004. The pituitary adenylate cyclase-activating polypeptide is a physiological inhibitor of platelet activation. J. Clin. Invest. 113:905.
18. Lejeune, M., A. Ferster, B. Cantinieaux, and E. Sariban. 1998. Prolonged but reversible neutrophil dysfunctions differentially sensitive to granulocyte colony-stimulating factor in children with acute lymphoblastic leukaemia. Br. J. Haematol. 102:1284.
19. Kleiner, D. E., and W. G. Stetler-Stevenson. 1994. Quantitative zymography: detection of picogram quantities of gelatinases. Anal. Biochem. 218:325.
20. Hallet, M. B., and D. Lloyds. 1995. Neutrophil priming: the cellular signals that say "amber" but not "green." Immunol. Today 16:264.
21. Borregaard, N., and J. B. Cowland. 1997. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 89:3503.
22. Pozo, D., M. Delgado, C. Martinez, R. P. Gomariz, J. M. Guerrero, and J. R. Calvo. 1997. Functional characterization and mRNA expression of pituitary adenylate cyclase activating polypeptide (PACAP) type I receptors in rat peritoneal macrophages. Biochim. Biophys. Acta 1359:250.
23. Park, S. K., T. A. Olson, N. Ercal, M. Summers, and M. S. O'Dorisio. 1996. Characterization of vasoactive intestinal peptide receptors on human megakaryocytes and platelets. Blood 87:4629.
24. Delgado, M., C. Abad, C. Martinez, M. G. Juarranz, J. Leceta, D. Ganea, and R. P. Gomariz. 2003. PACAP in immunity and inflammation. Ann. NY Acad. Sci. 992:141.
25. Delgado, M., E. J. Munoz-Elias, R. P. Gomariz, and D. Ganea. 1999. VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages: subsequent effect on IFNγ synthesis by T cells. J. Neuroimmunol. 96:167.
26. Thompson, H. L., C. J. Marshall, and J. Saklatvala. 1996. Characterization of two different forms of mitogen-activated protein kinase kinase induced in polymophonuclear leukocytes following stimulation by N-formylmethionyl-leucyl-phenylalanine or granulocyte-macrophage colony-stimulating factor. J. Biol. Chem. 269:9486.
27. Nick, J. A., N. J. Avdi, S. K. Young, C. Knall, P. Gerwins, G. L. Johnson, and G. S. Worthen. 1997. Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP. J. Clin. Invest. 99:975.
28. Kutsuna, H., K. Suzuki, N. Kamata, T. Kato, F. Hato, K. Mizuno, H. Kobayashi, M. Ishii, and S. Kitagawa. 2004. Actin reorganization and morphological changes in human neutrophils stimulated by TNF, GM-CSF, and G-CSF: the role of MAP kinases. Am. J. Physiol. 286:C55.
29. phox phosphorylation in human neutrophils. J. Immunol. 165:5238.
30. Chang, L. C., and J. P. Wang. 2001. Signal transduction pathways for activation of extracellular signal-regulated kinase by arachidonic acid in rat neutrophils. J. Leukocyte Biol. 69:659.
31. Nick, J. A., N. J. Avdi, P. Gerwins, G. L. Johnson, and G. S. Worthen. 1996. Activation of a p38 mitogen-activated protein kinase in human neutrophils by lipopolysaccharide. J. Immunol. 156:4867.
32. Meshki, J., F. Tuluc, O. Bredetean, Z. Ding, and S. P. Kunapuli. 2004. Molecular mechanism of nucleotide-induced primary granule release in human neutrophils: role for the P2Y2 receptor. Am. J. Physiol. 286:C264.
33. Smolen, J. E., T. K. Petersen, C. Koch, S. J. O'Keefe, W. A. Hanlon, S. Seo, D. Pearson, M. C. Fossett, and S. I. Simon. 2000. L-selectin signaling of neutrophil adhesion and degranulation involves p38 mitogen-activated protein kinase. J. Biol. Chem. 275:15876.
34. El Bekay, R., M. Alvarez, J. Monteseirin, G. Alba, P. Chacon, A. Vega, J. Martin-Nieto, J. Jimenez, E. Pintado, F. J. Bedoya, and F. Sobrino. 2003. Oxidative stress is a critical mediator of the angiotensin II signal in human neutrophils: involvement of mitogen-activated protein kinase, calcineurin, and the transcription factor NF-κB. Blood 102:662.
35. McLeish, K. R., C. Knall, R. A. Ward, P. Gerwins, P. Y. Coxon, J. B. Klein, and G. L. Johnson. 1998. Activation of mitogen-activated protein kinase cascades during priming of human neutrophils by TNF-α and GM-CSF. J. Leukocyte Biol. 64:537.
36. Frodin, M., P. Peraldi, and E. Van Obberghen. 1994. Cyclic AMP activates the mitogen-activated protein kinase cascade in PC12 cells. J. Biol. Chem 269:6207.
37. Barrie, A. P., A. M. Chohessy, C. S. Buensuceso, M. V. Rogers, and J. M. Allen. 1997. Pituitary adenylyl cyclase-activating peptide stimulates extracellular signal-regulated kinase 1 or 2 (ERK1/2) activity in a Ras-independent, mitogen-activated protein kinase/ERK kinase or 2-dependent manner in PC12 cells. J. Biol. Chem. 272:19666.
38. Villalba, M., J. Bockaert, and L. Journot. 1997. Pituitary adenylate cyclase-activating polypeptide (PACAP-38) protects cerebellar granule neurons from apoptosis by activating the mitogen-activated protein kinase (MAP kinase) pathway. J. Neurosci. 17:83.
39. Moroo, I., I. Tatsuno, D. Uchida, T. Tanaka, J. Saito, Y. Saito, and A. Hirai. 1998. Pituitary adenylate cyclase activating polypeptide (PACAP) stimulates mitogen-activated protein kinase (MAPK) in cultured rat astrocytes. Brain Res. 795:191.
40. McMullen, M., R. Keller, M. Sussman, and K. Pumiglia. 2004. Vascular endothelial growth factor-mediated activation of p38 is dependent upon Src and RAFTK/Pyk2. Oncogene 23:1275.
41. Liu, J., Z. Liu, S. Chuai, and X. Shen. 2003. Phospholipase C and phosphatidylinositol 3-kinase signaling are involved in the exogenous arachidonic acid-stimulated respiratory burst in human neutrophils. J. Leukocyte Biol. 74:428.
42. Yamamori, T., O. Inanami, H. Sumimoto, T. Akasaki, H. Nagahata, and M. Kuwabara. 2002. Relationship between p38 mitogen-activated protein kinase and small GTPase Rac for the activation of NADPH oxidase in bovine neutrophils. Biochem. Biophys. Res. Commun. 293:1571.
43. 2+/calmodulin regulated signaling pathways in chemoattractant induced neutrophil effector functions: comparison with the role of phosphotidylinositol-3 kinase. Eur. J. Biochem. 269:4625.
44. Downey, G. P., J. R. Butler, H. Tapper, L. Fialkow, A. R. Saltiel, B. B. Rubin, and S. Grinstein. 1998. Importance of MEK in neutrophil microbicidal responsiveness. J. Immunol. 160:434.
45. 558-containing granules. J. Biol. Chem. 275:36713.
46. Mocsai, A., Z. Jakus, T. Vantus, G. Berton, C. A. Lowell, and E. Ligeti. 2000. Kinase pathways in chemoattractant-induced degranulation of neutrophils: the role of p38 mitogen-activated protein kinase activated by Src family kinases. J. Immunol. 164:4321.
47. Rubel, C., G. C. Fernandez, F. A. Rosa, S. Gomez, M. B. Bompadre, O. A. Coso, M. A. Isturiz, and M. S. Palermo. 2002. Soluble fibrinogen modulates neutrophil functionality through the activation of an extracellular signal-regulated kinase-dependent pathway. J. Immunol. 168:3527.
48. Coxon, P. Y., M. J. Rane, S. Uriarte, D. W. Powell, S. Singh, W. Butt, Q. Chen, and K. R. McLeish. 2003. MAPK-activated protein kinase-2 participates in p38 MAPK-dependent and ERK-dependent functions in human neutrophils. Cell. Signal. 15:993.
49. Kasper, B., E. Brandt, S. Bulfone-Paus, and F. Petersen. 2004. Platelet factor 4 (PF-4)-induced neutrophil adhesion is controlled by Src-kinases, whereas PF-4-mediated exocytosis requires the additional activation of p38 MAP kinase and phosphatidylinositol 3-kinase. Blood 103:1602.
50. Jackson, J. K., C. Tudan, and H. M. Burt. 2000. The involvement of phospholipase C in crystal induced human neutrophil activation. J. Rheumatol 27:2877.
51. 2. Blood 97:2469.
52. Teng, C. H., F. C. Ke, M. T. Lee, S. W. Lin, L. Chen, and J. J. Hwang. 2000. Pituitary adenylate cyclase-activating polypeptide acts synergistically with relaxin in modulating ovarian cell function in rats. J. Endocrinol. 167:61.
53. Heissig, B., K. Hattori, S. Dias, M. Friedrich, B. Ferris, N. R. Hackett, R. G. Crystal, P. Besmer, D. Lyden, M. A. Moore, Z. Werb, and S. Rafii. 2002. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109:625.
54. Van Den Steen, P. E., A. Wuyts, S. J. Husson, P. Proost, J. Van Damme, and G. Opdenakker. 2003. Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities. Eur. J. Biochem. 270:3739.
55. Dumortier, A., P. Kirstetter, P. Kastner, and S. Chan. 2003. Ikaros regulates neutrophil differentiation. Blood 101:2219.
56. Dorsam, G., and E. Goetzl. 2002. Vasoactive intestinal peptide receptor-1 (VPAC-1) is a novel gene target of the hemolymphopoietic transcription factor Ikaros. J. Biol. Chem. 277:13488.
57. Sawangjaroen, K., S. T. Anderson, and J. D. Curlewis. 1997. Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) on hormone secretion from sheep pituitary cells in vitro. J. Neuroendocrinol. 9:279.
58. 2+ concentration and stimulates somatodendritic vasopressin release in rat supraoptic neurons. J. Neuroendocrinol. 10:31.
59. Martinez, C., C. Abad, M. Delgado, A. Arranz, M. G. Juarranz, N. Rodriguez-Henche, P. Brabet, J. Leceta, and R. P. Gomariz. 2002. Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor. Proc. Natl. Acad. Sci. USA 99:1053.
60. Elenkov, I. J., R. L. Wilder, G. P. Chrousos, and E. S. Vizi. 2000. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 52:595.